GLP-1s are changing the game
Dermatol 128 , 214222 (2008)
In our cohort, the observed improvement in %EWL following semaglutide administration supports the mechanistic hypothesis that post-surgical weight regain may, in part, be driven by diminishing endogenous incretin responses, which can be partially reversed with pharmacological GLP-1 receptor agonist therapy
stomach cytoprotection organoprotection of the entire digestive tract Cytoprotection, concerning the entire digestive system, includes changes of even the most complex nature, e.g., in cases of internal and external fistulas or severe colitis
by Julia Lloyd, MPH, RD, LDN, CDCES Spring 2026 GLP-1 medications are changing how people manage weight, blood sugar and metabolic health